COVAXIN – Bharat Biotech announces phase 3 results, 81% efficacy of 1 min read English News COVAXIN – Bharat Biotech announces phase 3 results, 81% efficacy of ADMIN March 4, 2021 Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today...Read More
